-
公开(公告)号:CA2360227A1
公开(公告)日:2000-07-20
申请号:CA2360227
申请日:2000-01-07
Applicant: BASF AG
Inventor: EASON RAYMOND , THOMPSON RICHARD C , MULLER BERND W , HACH HARALD , EINIG HEINZ
IPC: A61K9/20 , A61K31/19 , A61K31/192 , A61K31/485 , A61K31/52 , A61K45/00 , A61K47/14 , A61K47/30 , A61K47/36 , A61K47/38 , A61P27/16 , A61P29/00 , A61K31/137 , A61K31/522
Abstract: A pharmaceutical mixture comprising a profen and one or more additional acti ve compounds is described which has a total active compound content of over 85 % and contains up to 1 %, based on the content of the profen, of a nonionic surfactant having an HLB of >= 9 and a customary disintegrant and a lubri cant.
-
公开(公告)号:PT1128820E
公开(公告)日:2004-07-30
申请号:PT00912425
申请日:2000-01-07
Applicant: BASF AG
Inventor: EINIG HEINZ , HACH HARALD , EASON RAYMOND , MULLER BERND W , THOMPSON RICHARD C
IPC: A61K9/20 , A61K31/19 , A61K31/192 , A61K31/485 , A61K31/52 , A61K45/00 , A61K47/14 , A61K47/30 , A61K47/36 , A61K47/38 , A61P27/16 , A61P29/00 , A61K31/522
Abstract: A pharmaceutical mixture comprising a profen and one or more additional active compounds is described which has a total active compound content of over 85% and contains up to 1%, based on the content of the profen, of a nonionic surfactant having an HLB of >=9 and a customary disintegrant and a lubricant.
-
公开(公告)号:CZ20012553A3
公开(公告)日:2001-10-17
申请号:CZ20012553
申请日:2000-01-07
Applicant: BASF AG
Inventor: EINIG HEINZ , HACH HARALD , EASON RAYMOND , MULLER BERND W , THOMPSON RICHARD C
IPC: A61K9/20 , A61K31/19 , A61K31/192 , A61K31/485 , A61K31/52 , A61K45/00 , A61K47/14 , A61K47/30 , A61K47/36 , A61K47/38 , A61P27/16 , A61P29/00 , A61K31/522
Abstract: A pharmaceutical mixture comprising a profen and one or more additional active compounds is described which has a total active compound content of over 85% and contains up to 1%, based on the content of the profen, of a nonionic surfactant having an HLB of >=9 and a customary disintegrant and a lubricant.
-
公开(公告)号:AU3420600A
公开(公告)日:2000-08-01
申请号:AU3420600
申请日:2000-01-07
Applicant: BASF AG
Inventor: EINIG HEINZ , HACH HARALD , EASON RAYMOND , MULLER BERND W , THOMPSON RICHARD C
IPC: A61K9/20 , A61K31/19 , A61K31/192 , A61K31/485 , A61K31/52 , A61K45/00 , A61K47/14 , A61K47/30 , A61K47/36 , A61K47/38 , A61P27/16 , A61P29/00 , A61K31/522
Abstract: A pharmaceutical mixture comprising a profen and one or more additional active compounds is described which has a total active compound content of over 85% and contains up to 1%, based on the content of the profen, of a nonionic surfactant having an HLB of >=9 and a customary disintegrant and a lubricant.
-
公开(公告)号:ES2218138T3
公开(公告)日:2004-11-16
申请号:ES00912425
申请日:2000-01-07
Applicant: BASF AG
Inventor: EINIG HEINZ , HACH HARALD , EASON RAYMOND , MULLER BERND W , THOMPSON RICHARD C
IPC: A61K9/20 , A61K31/19 , A61K31/192 , A61K31/485 , A61K31/52 , A61K45/00 , A61K47/14 , A61K47/30 , A61K47/36 , A61K47/38 , A61P27/16 , A61P29/00 , A61K31/522
Abstract: A pharmaceutical mixture comprising a profen and one or more additional active compounds is described which has a total active compound content of over 85% and contains up to 1%, based on the content of the profen, of a nonionic surfactant having an HLB of >=9 and a customary disintegrant and a lubricant.
-
公开(公告)号:CZ20012228A3
公开(公告)日:2002-07-17
申请号:CZ20012228
申请日:1999-12-14
Applicant: BASF AG
Inventor: EINIG HEINZ , HACH HARALD , THOMPSON RICHARD C , EASON RAYMOND , MULLER BERND W
Abstract: A pharmaceutical mixture comprising a profen is described which has a profen content of over 85 % and contains up to 1% of a nonionic surfactant having an HLB of >/=9 and also a customary disintegrant and a lubricant and optionally a microcrystalline cellulose.
-
公开(公告)号:CA2464756A1
公开(公告)日:2003-05-15
申请号:CA2464756
申请日:2002-10-25
Applicant: BASF AG
Inventor: MULLER BERND W , FRIESE KATRIN , RASENACK NORBERT , EINIG HEINZ , FRANKE DIRK
IPC: A61K9/20 , A61K9/14 , A61K9/16 , A61K9/26 , A61K31/192 , A61P29/00 , C07C51/43 , C07C51/50 , C07C57/30 , C07C59/64
Abstract: The invention relates to a method for the formation of ibuprofen crystals, characterised in that the solidification occurs after crystallisation by displacement, crystallisation by cooling, crystallisation by evaporation or a combination thereof in the presence of one or several additives and the use of the ibuprofen produced as above for pharmaceutical formulations.
-
-
-
-
-
-